Medicare Enrolled

Dr. Yamin Sun, MD

Hematology · Gainesville, GA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
725 JESSE JEWELL PKWY SE, Gainesville, GA 30501
7702975700
Registered in NPPES since 2014
NPI: 1801216080 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sun? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sun

Dr. Yamin Sun is a hematology specialist in Gainesville, GA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Sun performed 25,253 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Sun received a total of $14,983 from 77 pharmaceutical and/or device companies across 690 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sun is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years of NPI registration ▲ Top 8% volume in GA $14,983 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
25,253
Medicare services
Top 8% in GA for hematology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme)
An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis.
18,360 $0 $5
Denosumab injection (Prolia/Xgeva) 2,280 $18 $32
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
812 $0 $2
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
508 $8 $30
Injection, granisetron hydrochloride, 100 mcg 500 $0 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
488 $92 $160
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
476 $8 $45
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
380 $10 $65
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
237 $129 $225
Annual depression screening 134 $17 $40
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
119 $6 $300
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
110 $10 $40
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
105 $95 $650
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
104 $46 $170
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
97 $21 $95
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
76 $13 $100
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
69 $1 $10
New patient office visit, complex (60-74 min) 64 $167 $310
Enhanced Oncology Model monthly payment
This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients.
58 $70 $115
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $60 $115
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
40 $47 $350
Principal care management for high-risk disease, first 30 minutes
This service involves 30 minutes of personal care management by a qualified healthcare professional for a patient with a single high-risk disease, billed per calendar month.
38 $62 $116
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
22 $116 $245
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
21 $29 $130
Iron level test 21 $6 $35
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
21 $9 $40
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
20 $8 $50
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
17 $15 $110
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
16 $135 $325
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
14 $48 $115
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
74.1% high complexity
15.4% medium
10.5% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,983
Total received (2018-2024)
Avg $2,140/year across 7 years
Top 46% in GA for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
77
Companies
690
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,487
2023
$3,320
2022
$3,281
2021
$2,869
2020
$1,045
2019
$855
2018
$125

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$309
Janssen Biotech, Inc.
$292
PFIZER INC.
$259
ABBVIE INC.
$209
Genentech USA, Inc.
$202
Merck Sharp & Dohme LLC
$200
Celgene Corporation
$165
Daiichi Sankyo Inc.
$158
GlaxoSmithKline, LLC.
$134
E.R. Squibb & Sons, L.L.C.
$114
AstraZeneca Pharmaceuticals LP
$96
Regeneron Healthcare Solutions, Inc.
$89
Incyte Corporation
$87
Bayer Healthcare Pharmaceuticals Inc.
$84
Gilead Sciences, Inc.
$72
Lilly USA, LLC
$70
Eisai Inc.
$70
ARRAY BIOPHARMA INC
$68
Exelixis Inc.
$61
Aveo Pharmaceuticals, Inc.
$60
Rigel Pharmaceuticals, Inc.
$59
Takeda Pharmaceuticals U.S.A., Inc.
$53
Coherus Biosciences Inc.
$53
SERVIER PHARMACEUTICALS LLC
$52
Tempus AI, Inc
$52
Astellas Pharma US Inc
$50
Sumitomo Pharma America, Inc.
$46
JAZZ PHARMACEUTICALS INC.
$44
Mirati Therapeutics, Inc.
$44
PUMA BIOTECHNOLOGY, INC.
$43
Deciphera Pharmaceuticals Inc.
$37
Stemline Therapeutics Inc.
$22
BeiGene USA, Inc.
$22
SOBI, INC
$20
Acrotech Biopharma Inc.
$19
PharmaEssentia USA Corporation
$19
Alexion Pharmaceuticals, Inc.
$18
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
GENZYME CORPORATION
$17
Top 3 companies account for 24.7% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,192
AstraZeneca Pharmaceuticals LP
$757
Exelixis Inc.
$750
Celgene Corporation
$746
Genentech USA, Inc.
$688
Seagen Inc.
$687
Incyte Corporation
$683
Merck Sharp & Dohme LLC
$666
E.R. Squibb & Sons, L.L.C.
$661
Daiichi Sankyo Inc.
$583
Janssen Biotech, Inc.
$578
PFIZER INC.
$441
Amgen Inc.
$358
GlaxoSmithKline, LLC.
$331
Takeda Pharmaceuticals U.S.A., Inc.
$328
GENZYME CORPORATION
$320
Bayer HealthCare Pharmaceuticals Inc.
$259
Gilead Sciences, Inc.
$252
Regeneron Healthcare Solutions, Inc.
$251
Jazz Pharmaceuticals Inc.
$226
Eisai Inc.
$225
Lilly USA, LLC
$223
ABBVIE INC.
$209
JAZZ PHARMACEUTICALS INC.
$188
Rigel Pharmaceuticals, Inc.
$186
Pharmacyclics LLC, An AbbVie Company
$185
Astellas Pharma US Inc
$181
TerSera Therapeutics LLC
$166
EISAI INC.
$162
Coherus Biosciences Inc.
$151
Bayer Healthcare Pharmaceuticals Inc.
$131
Merck Sharp & Dohme Corporation
$123
Alexion Pharmaceuticals, Inc.
$108
Boehringer Ingelheim Pharmaceuticals, Inc.
$88
Octapharma USA, Inc.
$86
AbbVie Inc.
$84
ARRAY BIOPHARMA INC
$84
Deciphera Pharmaceuticals Inc.
$82
Aveo Pharmaceuticals, Inc.
$77
BeiGene USA, Inc.
$76
EMD Serono, Inc.
$75
MorphoSys, US Inc.
$74
Pharmacyclics LLC, an AbbVie Company
$70
Sumitomo Pharma America, Inc.
$68
SERVIER PHARMACEUTICALS LLC
$68
Epizyme, Inc.,
$66
Acceleron Pharma, Inc.
$58
PUMA BIOTECHNOLOGY, INC.
$57
Dova Pharmaceuticals
$55
Puma Biotechnology, Inc.
$55
AVEO Pharmaceuticals, Inc.
$53
Tempus AI, Inc
$52
Acrotech Biopharma LLC
$49
Mirati Therapeutics, Inc.
$44
Karyopharm Therapeutics Inc.
$39
Blueprint Medicines Corporation
$39
ADC Therapeutics America, Inc.
$36
Myovant Sciences Inc.
$34
Ipsen Biopharmaceuticals, Inc
$33
Acrotech Biopharma Inc.
$33
Sun Pharmaceutical Industries Inc.
$32
Foundation Medicine, Inc.
$30
Servier Pharmaceuticals LLC
$27
TAIHO ONCOLOGY, INC.
$27
Tolmar, Inc.
$26
ImmunoGen, Inc.
$24
Stemline Therapeutics Inc.
$22
Heron Therapeutics, Inc.
$21
SOBI, INC
$20
PharmaEssentia USA Corporation
$19
SUN PHARMACEUTICAL INDUSTRIES INC.
$18
CTI BioPharma Corp.
$17
Agios Pharmaceuticals, Inc.
$16
Kite Pharma, Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$15
Taiho Oncology, Inc.
$13
AMAG Pharmaceuticals, Inc.
$12
Top 3 companies account for 18.0% of all-time payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · ALUNBRIG · AYVAKIT · Alecensa · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · CUTAQUIG · CYRAMZA · Cabometyx · Columvi · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELREXFIO · ENHERTU · EPKINLY · ERBITUX · Elahere · Enhertu · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · Fabhalta · GAVRETO · GILOTRIF · Halaven · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NERLYNX · NINLARO · Nplate · Nubeqa · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PROMACTA · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Stivarga · TAGRISSO · TALVEY · TAZVERIK · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XERMELO · XGEVA · XPOVIO · XTANDI · Xermelo · Xospata · YONSA · ZEJULA · ZEPZELCA · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology specialist in Gainesville?
Compare hematologists in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse hematologists nearby

Geographic Context

Hematologists in nearby ZIP areas
7
County median income
$77,430
Nearest hospital to ZIP centroid (approximate)
NORTHEAST GEORGIA MEDICAL CENTER, INC
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Sun is a mixed practice specialist, with above-average Medicare volume (top 8% in GA).

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Sun experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sun performed 18,360 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sun receive payments from pharmaceutical companies?
Yes. Dr. Sun received a total of $14,983 from 77 companies across 690 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sun's costs compare to other hematologists in Gainesville?
Dr. Sun's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →